G. R. Pantalone

Long‐term use of deferiprone significantly enhances left‐ventricular ejection function in thalassemia major patients

P. Cianciulli, L. Cuccia, G. D'Ascola, 2012, American journal of hematology.

Marked impact of IL28B genotype in the natural clearance of hepatitis C virus in patients with haemoglobinopathies

M. Cottone, A. Maggio, D. Renda, 2011, British Journal of Haematology.

Desensitization to hydroxycarbamide following long‐term treatment of thalassaemia intermedia as observed in vivo and in primary erythroid cultures from treated patients

R. Calzolari, A. Maggio, A. Pecoraro, 2010, British journal of haematology.

Sequential Alternating Deferiprone And Deferoxamine Treatment Compared To Deferiprone Monotherapy: Main Findings And Clinical Follow-Up Of A Large Multicenter Randomized Clinical Trial In -Thalassemia Major Patients

G. D’Amico, A. Morabito, C. Gluud, 2011, Hemoglobin.